Clinical trial
FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
NCT00383136 · University of Bologna, Other · Completed
Key facts
| NCT number | NCT00383136 |
|---|---|
| Title | FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab |
| Official title | FATA: Comparison Between Tirofiban and Abciximab in Facilitated Angioplasty With Stent Implantation: Randomized Multicentre Study |
| Acronym | FATA |
| Lead sponsor | University of Bologna, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | tirofiban high-bolus dose regimen, Abciximab |
| Enrollment | 692 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Oct 2, 2006 |
| Last update posted | Jan 16, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: